Vitamin D has been found to speed up the clearance of tuberculosis (TB) bacteria from the lungs of people with multi-drug resistant TB, according to a study of 1,850 patients receiving antibiotic treatment, led by Queen Mary University of London.

Cure rates for multidrug-resistant tuberculosis (MDR-TB) in Europe have been estimated to be twice as high as previously thought, according to a research team at Queen Mary University of London (QMUL).

The Medical Research Council (MRC) has awarded a grant of £3.5m to researchers from Queen Mary University of London (QMUL) and University of Cape Town (UCT) to carry out a trial to determine whether a weekly vitamin D supplement can prevent tuberculosis (TB) in South African primary school children.

A research to investigate for the first time the effect of vitamin D on the immune responses of patients receiving treatment for an infectious disease.